GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » U-Neuron Biomedical Inc (ROCO:6973) » Definitions » Price-to-Owner-Earnings

U-Neuron Biomedical (ROCO:6973) Price-to-Owner-Earnings : (As of Jun. 01, 2024)


View and export this data going back to 2023. Start your Free Trial

What is U-Neuron Biomedical Price-to-Owner-Earnings?

As of today (2024-06-01), U-Neuron Biomedical's share price is NT$47.90. U-Neuron Biomedical does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for U-Neuron Biomedical's Price-to-Owner-Earnings or its related term are showing as below:


ROCO:6973's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 32.61
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-01), U-Neuron Biomedical's share price is NT$47.90. U-Neuron Biomedical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-3.78. Therefore, U-Neuron Biomedical's PE Ratio for today is At Loss.

As of today (2024-06-01), U-Neuron Biomedical's share price is NT$47.90. U-Neuron Biomedical's EPS without NRI for the trailing twelve months (TTM) ended in was NT$-3.78. Therefore, U-Neuron Biomedical's PE Ratio without NRI for today is At Loss.


U-Neuron Biomedical Price-to-Owner-Earnings Historical Data

The historical data trend for U-Neuron Biomedical's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U-Neuron Biomedical Price-to-Owner-Earnings Chart

U-Neuron Biomedical Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
- - - -

U-Neuron Biomedical Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Owner-Earnings - - - - -

Competitive Comparison of U-Neuron Biomedical's Price-to-Owner-Earnings

For the Biotechnology subindustry, U-Neuron Biomedical's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


U-Neuron Biomedical's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, U-Neuron Biomedical's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where U-Neuron Biomedical's Price-to-Owner-Earnings falls into.



U-Neuron Biomedical Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

U-Neuron Biomedical's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=47.90/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


U-Neuron Biomedical  (ROCO:6973) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


U-Neuron Biomedical Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of U-Neuron Biomedical's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


U-Neuron Biomedical (ROCO:6973) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.

U-Neuron Biomedical (ROCO:6973) Headlines

No Headlines